热门资讯> 正文
BRIEF-Seneca Biopharma Announces Completion Of Phase II Clinical Study In China For Treatment Of Ischemic Stroke
2020-09-10 21:10
Sept 10 (Reuters) - Seneca Biopharma Inc :
* SENECA BIOPHARMA, INC. ANNOUNCES COMPLETION OF PHASE II CLINICAL STUDY IN CHINA FOR TREATMENT OF ISCHEMIC STROKE
* SENECA BIOPHARMA INC - REMAINS ON SCHEDULE TO RELEASE TOP LINE DATA FOR PHASE 2 STUDY DURING Q4 OF 2020
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
